These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16007735)

  • 1. Golden opportunities.
    Smaglik P
    Nature; 2005 Jul; 436(7047):144-7. PubMed ID: 16007735
    [No Abstract]   [Full Text] [Related]  

  • 2. Value creation and sharing among universities, biotechnology and pharma.
    Edwards MG; Murray F; Yu R
    Nat Biotechnol; 2003 Jun; 21(6):618-24. PubMed ID: 12776145
    [No Abstract]   [Full Text] [Related]  

  • 3. Biotechs hold their own in shifting industry.
    Mitchell P
    Nat Biotechnol; 2002 Nov; 20(11):1065-6. PubMed ID: 12410238
    [No Abstract]   [Full Text] [Related]  

  • 4. Blurred vision.
    Smaglik P
    Nature; 2002 Dec; 420(6916 Suppl):A19, A21, A23. PubMed ID: 12501122
    [No Abstract]   [Full Text] [Related]  

  • 5. Biotechnology partnerships--medicine for an ailing industry?
    DeLamarter J
    Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
    [No Abstract]   [Full Text] [Related]  

  • 6. Northern England: rising star.
    Smaglik P
    Nature; 2003 Sep; 425(6956):430-3. PubMed ID: 14508497
    [No Abstract]   [Full Text] [Related]  

  • 7. UK industry consolidation is slow despite big merger.
    Mitchell P
    Nat Biotechnol; 2003 Mar; 21(3):215. PubMed ID: 12610553
    [No Abstract]   [Full Text] [Related]  

  • 8. Financial Times Global Pharmaceutical & Biotechnology Conference 2009.
    Scattereggia J
    IDrugs; 2010 Jan; 13(1):26-9. PubMed ID: 20024844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisoma-Roche deal--a new kind of buyout?
    Mitchell P
    Nat Biotechnol; 2003 Jan; 21(1):3. PubMed ID: 12511894
    [No Abstract]   [Full Text] [Related]  

  • 10. Fresh horizons South Korea.
    Cyranoski D
    Nature; 2002 Dec; 420(6916):4-5. PubMed ID: 12478244
    [No Abstract]   [Full Text] [Related]  

  • 11. China's Zhejiang province is open for science business.
    O'Meara S
    Nature; 2018 May; 557(7707):S51-S52. PubMed ID: 29849161
    [No Abstract]   [Full Text] [Related]  

  • 12. Should platform companies move toward products?
    Ratner M
    Nat Biotechnol; 1999 Jan; 17(1):16-7. PubMed ID: 9920255
    [No Abstract]   [Full Text] [Related]  

  • 13. Cheap at any price?
    Ledford H
    Nature; 2007 May; 447(7141):131. PubMed ID: 17495898
    [No Abstract]   [Full Text] [Related]  

  • 14. Calling for entrepreneurs: London.
    Smaglik P
    Nat Biotechnol; 2002 Dec; 20(12):1281-2. PubMed ID: 12454679
    [No Abstract]   [Full Text] [Related]  

  • 15. Best of both worlds.
    Smaglik P
    Nature; 2003 Dec; 426(6967):706-7. PubMed ID: 14668875
    [No Abstract]   [Full Text] [Related]  

  • 16. Cementing links between industry and the university.
    Jennings R
    Nat Biotechnol; 1998 May; 16 Suppl():35-6. PubMed ID: 9591263
    [No Abstract]   [Full Text] [Related]  

  • 17. Corporate venture capital and Cambridge.
    McCammon MG; Pio E; Barakat S; Vyakarnam S
    Nat Biotechnol; 2014 Oct; 32(10):975-8. PubMed ID: 25299912
    [No Abstract]   [Full Text] [Related]  

  • 18. Curiosity makes way for capitalism.
    Cyranoski D
    Nature; 2004 May; 429(6988):216-9. PubMed ID: 15141220
    [No Abstract]   [Full Text] [Related]  

  • 19. AchemAsia 2007 announcement: China's biotechnology industry on the upswing.
    Biotechnol J; 2007 Mar; 2(3):288-90. PubMed ID: 17354215
    [No Abstract]   [Full Text] [Related]  

  • 20. [Change the world through business partnering - commercialization of biotechnology and open-innovation].
    Tsukamoto Y
    Nihon Yakurigaku Zasshi; 2013 May; 141(5):268-74. PubMed ID: 23665558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.